The nebulizer market is expected to reach US$1.44 billion in 2024, recording a CAGR of 4.02%, during 2020-2024. The factors such as, expansion of medical devices, upsurge in air pollution, growth in geriatric population, increasing medical technology R&D spending, rising prevalence of asthma, rapid urbanization and upsurge in healthcare expenditures would drive the growth of the market. However, the market growth would be challenged by high cost of mesh nebulizing therapy, side effects associated with the use of nebulizers and stringent government regulations. A few notable trends may include growing frequency of e-smoking, increasing focus on telehealth, bigger attention towards mesh nebulizers and increasing adoption of home nebulizing therapy.
The global nebulizer market is fragmented into jet nebulizer, mesh nebulizer and ultrasonic nebulizer. The market is highly concentrated with jet nebulizers owing to the low cost and easy accessibility factors. Although, people’s preferences are gradually shifting towards mesh nebulizers due to the compact size devices and minimized drug loss, thereby improving the effectiveness of the treatment. Ultrasonic nebulizers are growing steadily owing to a wider range of benefits such as increased portability, low drug delivery time and low noise, which are providing a scope for its market growth.
The fastest regional market was North America owing to the growing prevalence of chronic respiratory disorders and continuous advancement in medical technology. Other regions also secured considerable shares in the global market due to rise in favourable reimbursement scenario, rise in customer awareness and well-established healthcare infrastructure. Furthermore, the sudden outbreak of COVID-19 is creating a huge demand for various respiratory devices, providing strong grounds for market growth of nebulizers globally.
Scope of the report:
The report provides a comprehensive analysis of the global nebulizer (Jet, Mesh & Ultrasonic) market. The major regional markets (North America, Europe, Asia-Pacific, Middle East & Africa and Latin America) have been analyzed. The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth. The competitive landscape of the market, along with the company profiles of leading players (Koninklijke Philips, Becton, Dickson an Company, Omron Corporation, Agilent Technologies, Teleflex Incorporated and Invacare Corporation) are also presented in detail.
Key Target Audience:
Nebulizers Manufacturers Medical Technology Firms End Users (Hospitals, Clinics, Emergency Centers, Home care) Investment Banks Healthcare and Medical Consultants Government Bodies & Regulating Authorities
Our reports have been used by over 10K customers, including:
The global respiratory care devices market exhibited strong growth during 2015-2020. Respiratory care devices refer to the medical equipment used for the diagnosis, treatment, assessment and care of patients suffering from pulmonary diseases. Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers,...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the respiratory disposables market are Fisher & Paykel, Becton Dickinson Company, Ambu A/S, Smiths Medical, and Armstrong Medical. The global respiratory disposables market is expected to decline from $4.52 billion in 2020 to $3.74 billion in 2021 at a compound annual growth rate (CAGR) of -17.3%. The change in growth...
175 pages •
By The Business Research Company
• Apr 2021
Major players in the nebulizer devices market are Agilent Technologies, Becton Dickinson and Company, Koninklijke Philips N.V., Omron Corporation, Covidien plc, GE Healthcare Ltd., Allied Healthcare Products, Inc, Briggs Healthcare, PARI Pharma, and GF Health Products, Inc. The global nebulizers market is expected to decline from $1.67...
Scope of the Report The report titled “Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in-depth analysis of the global respiratory care medical devices market with description of market sizing and growth. The analysis includes market by value and market share by...
The respiratory ventilator tester market was valued at US$ 148.00 million in 2019 and is projected to reach US$ 199.20 million by 2027; it is expected to grow at a CAGR of 3.8% from 2020 to 2027. The growth of the market is mainly attributed to factors such as growing prevalence of respiratory diseases and increasing geriatric population....
Nebulizers (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)
Nebulizers (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within...
Humidifiers (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)
Humidifiers (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within...
The global respiratory care devices market is expected to reach nearly US$ 35 Billion by 2026. Respiratory care is a healthcare specialty, which is focused on improving cardiopulmonary functions and promoting health & wellness. Respiratory care devices are used for the diagnosis, treatment, and monitoring of patients who are suffering from...
The Europe pulmonary devices market is expected to reach US$ 11,398.02 million by 2027 from US$ 5,459.48 million in 2019. The market is estimated to grow at a CAGR of 9.7% during 2019–2027. The growth of the pulmonary devices market in Europe is attributed to the increasing prevalence of respiratory diseases and growing number of COVID-19...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.